Skip to content

Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19)

Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029789
Enrollment
Unknown
Registered
2020-02-13
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

The First Affiliated Hospital of He'nan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. General/severe/critical patients who meet the diagnostic criteria of new coronavirus pneumonia; 2. Patients whose viral nucleic acid has turned negative after treatment; 3. Patients who are characterized by respiratory symptoms such as cough, shortness of breath, chest tightness or corresponding chest imaging features; 4. Patients who meet TCM syndrome; 5. Patients who voluntarily participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with cognitive disorder or known mental illness; 2. Pregnant or lactating women; 3. Patients with active tuberculosis, pulmonary abscess or chronic respiratory failure; 4. Patients with tumor; 5. Patients with severe liver or kidney diseases; 6. Patients with severe cardiovascular or cerebrovascular diseases; 7. Patients who are participating in clinical trials of other drugs, or known to be allergic to therapeutic drugs.

Design outcomes

Primary

MeasureTime frame
St. George's Respiratory Questionnaire;

Secondary

MeasureTime frame
Chest imaging;6-minute walking distance;Pulmonary function;EQ-5D;All-cause readmission;Patient-reported outcome for pneumonia;

Countries

China

Contacts

Public ContactLi Jiansheng

He'nan University of Chinese Medicine

li_js8@163.com+86 371-65676568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026